Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
Q2 2021 vs. Q1 2021
How the institutions holding Adma Biologics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 104 | 90 | −14 |
| Shares | 48.5M | 42.9M | −5.65M (−11.6%) |
| Value | $85.4M | $68.6M | −$16.8M (−19.7%) |
New holders (17)
Institutions that held Adma Biologics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 1,002,136 | $1.60M | 0.00% |
| Ergoteles LLC | 299,500 | $479.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 211,692 | $339.0K | 0.00% |
| Renaissance Technologies LLC | 175,626 | $281.0K | 0.00% |
| LMR Partners LLP | 42,622 | $68.0K | 0.00% |
| Natixis | 37,200 | $60.0K | 0.00% |
| XTX Topco Ltd | 24,881 | $40.0K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 16,656 | $27.0K | 0.01% |
| Alpine Global Management, LLC | 10,645 | $17.0K | 0.00% |
| ARGI Investment Services, LLC | 10,000 | $16.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 1,600 | $2.00K | 0.00% |
| Captrust Financial Advisors | 1,084 | $2.00K | 0.00% |
| Advisory Services Network, LLC | 500 | $1.00K | 0.00% |
| Global Wealth Management Investment Advisory, Inc. | 500 | $1.00K | 0.00% |
| Center for Financial Planning, Inc. | 380 | $1.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| Heritage Wealth Management, LLC | 100 | – | – |
Sold out (31)
Institutions that held Adma Biologics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.